Cannara Biotech Inc.
LOVE.V
TSX
| 11/30/2025 | 08/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 4.88% | 5.93% | |||
| Total Other Revenue | -90.37% | -- | |||
| Total Revenue | 3.74% | 7.21% | |||
| Cost of Revenue | 15.17% | 14.40% | |||
| Gross Profit | -11.13% | -0.90% | |||
| SG&A Expenses | 23.43% | 13.46% | |||
| Depreciation & Amortization | -66.30% | 257.28% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 14.96% | 16.74% | |||
| Operating Income | -47.87% | -22.06% | |||
| Income Before Tax | -55.84% | -19.64% | |||
| Income Tax Expenses | -19.84% | -23.76% | |||
| Earnings from Continuing Operations | -69.18% | -18.00% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -69.18% | -18.00% | |||
| EBIT | -47.87% | -22.06% | |||
| EBITDA | -42.92% | -5.78% | |||
| EPS Basic | -70.08% | -18.01% | |||
| Normalized Basic EPS | -51.00% | -29.08% | |||
| EPS Diluted | -67.12% | -22.89% | |||
| Normalized Diluted EPS | -51.28% | -29.86% | |||
| Average Basic Shares Outstanding | 2.49% | 0.01% | |||
| Average Diluted Shares Outstanding | 3.00% | 0.83% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||